Applying a bioactivity-guided isolation strategy for the ethanolic extract of crown gall tumours induced on an Eucalyptus tereticornis tree, two new compounds in addition to a known one were isolated. The new compounds were identifi ed as an amino acid derivative named 1-ethyl-6-(1'-methyl-1'-phenylethyl) piperidin-2-one (1) and a lanostane tetracyclic triterpene named 3β-hydroxy-24-methyllanosta-8,17(20),24(28)-trien-22-oic acid (2), together with stigmasterol-3-O-glucoside (3). The three compounds exhibited signifi cant cytotoxic activity against two human cell lines, breast (MCF7) and colon (HCT116), with IC 50 values of 1.01, 1.54, and 2.15 μg/ml, respectively, against MCF7 and 3.49, 3.83, and 3.39 μg/ ml, respectively, against HCT116. Furthermore, in rats elevated levels of blood cholesterol, triglycerides, and low-density lipoprotein (LDLc) were signifi cantly reduced, while the level of high-density lipoprotein (HDLc) was signifi cantly increased by administration of the etha nolic extract as well as of 3. These results support a correlation between the reduction of blood cholesterol levels and improvement of colorectal cancer.
Introduction
Microbial secondary metabolites represent a large source of compounds endowed with ingenious structures and potent biological activities. Novel antibiotics and other bioactive secondary metabolites can still be discovered from microbial sources. In the last few decades, these products have been obtained through intensive screening involving millions of microorganisms. However, not all microorganisms are equally capable of producing secondary metabolites. In fact, this capability is restricted to a few groups of bacterial or eukaryotic microbes (Donadio et al., 2002) .
Agrobacterium tumefaciens (revised scientifi c name: Rhizobium radiobacter) (Young et al., 2001 ) is the causal agent of crown gall disease defi ned as the formation of tumours in over 140 species of Dicotyledons. It is a Gram-negative, soil-born bacterium occurring in different strains, some of which are virulent, while others are avirulent. To be virulent, the strain must contain a tumour-inducing (Ti) plasmid which is responsible for crown gall formation (Escudero et al., 1995) . Symptoms are caused by the insertion of a small segment of DNA (known as T-DNA, for transfer DNA) into the plant cell which is incorporated at a semi-random location into the plant genome (Chilton et al., 1977) . The infection usually occurs during the rainy seasons and/or after cutting trees in relatively humid environment.
In the last decades, crown gall tumour tissues have attracted great interest related to the study and isolation of bioactive metabolites, as well as their biosynthesis and metabolism (Morris et al., 1982; Palni and Horgan, 1983; Hanold, 1993; Stahlhut, 1994) . Some unusual amino acid derivatives not ordinarily detected in normal cells have been found in crown gall tumours. These compounds were identifi ed as N 2 -(1-carboxyethyl)-L-amino acids, N 2 -(1,3-dicarboxypropyl)-L-amino acids, N 2 -(1'-deoxy-D-mannitol-1'-yl)-L-glutamine-1,2'-lactone (agropine) (Biemann et al., 1960; Mé-nage and Morel, 1964; Chilton et al., 1977; Kemp, 1977; Coxon et al., 1980; Tate et al., 1982; Chang et al., 1983) ine (Firmin and Fenwick, 1977; Thompson, 1989) . Furthermore, indole alkaloids (Wang et al., 1994) , cardenolides (Luckner et al., 1990; Pinkwart et al., 1993) , and diterpenes (Ghosh and Mukerjee, 1997) have also been isolated from crown gall tumours. Cancer will remain a major cause of worldwide deaths in the 21 st century. More than 50% of the new cancer cases in the world occur in developing countries. Nearly 80% of the people living in developing countries still depend on plant-based traditional medicine for their primary health care, and almost three-fourths of the herbal drugs used worldwide are derived from medicinal plants (Verma and Singh, 2008) . Natural products from plants used in traditional medicines are currently one of the main sources in cancer chemo-preventive drug discovery (Abdullaev, 2001) . Considering the almost unlimited genetic variety of microorganisms and the multitude of secondary compounds formed by them, it is to be expected that compounds useful in cancer treatment will be found increasingly among microbial secondary metabolites (Umezawa, 1978) .
Breast carcinoma is the most prevalent cancer among Egyptian women and constitutes 29% (Omar et al., 2003) , while colorectal cancer affects younger population with an incidence of 2 to 6% (Khafagy et al., 2000) .
Globalization and the wide-spread of Western diet to the developing world have produced an explosive increase in the rates of obesity and hypercholesterolemia in those regions. Therefore, hypercholesterolemia and its associated cardiovascular diseases represent one of the greatest worldwide economic, social, and medical challenges that we are facing now (AHA, 2005; Olshansky et al., 2005) .
Crown galls are a source of bioactive metabolites, especially of such that possess both antihypercholesterolemic (Sato et al., 1996) and antineoplastic activities (Ghosh and Mukerjee, 1997) . Such compounds are attractive drug candidates, because recent research has uncovered a relationship between factors causing hypercholesterolemia and factors leading to some types of cancer, such as colorectal cancer (CRC) (Herbey et al., 2005) .
For this reason, we have investigated the phytoconstituents of a crown gall of an Eucalyptus tereticornis Sm. tree with the aim of isolating new secondary metabolites and studying their cytotoxic activity against two human cancer cell lines, breast (MCF7) and colon (HCT116). We wished to examine the ability of these metabolites to reduce risk factors and thus prevent hypercholesterolemia and CRC.
Material and Methods

Plant material
The host tree, a specimen of Eucalyptus tereticornis Sm. (Mysore Gum, Forest Red Gum), fa mily Myrtaceae, was growing in the garden of the campus of the School of Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia. The tree (23 m in height, 6 years old) was identifi ed by Dr. Wondo Genet, College of Forestry and Natural Resources (WGCF), Addis Ababa, Ethiopia. The crown gall tissues were obtained from the tumour induced on this tree.
Induction of crown gall tumour
The tumour was induced during the rainy season by incision of the stem of the tree with an axe infected with both Agrobacterium tumefaciens strain C58 [carrying a tumour-inducing plasmid (Ti plasmid)] and Agrobacterium rhizogenes (strain A4) [carrying a root-inducing plasmid (Ri plasmid)]. The tumour, 25 -27 cm in diameter and weighing about 350 g, was formed within two months, cut off and dried in an oven at 60 °C, and stored in a dry room. Both plasmids were identifi ed in the tumour tissue after infection using restriction analysis in the Microbiology Department, School of Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia. The tumour was easily powdered due to its spongy nature, kept in completely fi lled, tightly closed glass containers, and brought to Egypt by one of us (A. M. E.).
General procedures and materials
Silica gel H (Merck, Darmstadt, Germany) for vacuum liquid chromatography (VLC), silica gel 60 (70 -230 mesh ASTM; Fluka, Steinheim, Germany) for column chromatography (CC), and Sephadex LH 20 (Pharmacia, Stockholm, Sweden) were used. Thin-layer chromatography (TLC) was performed on silica gel GF254 precoated plates (Fluka). The chromatograms were visualized after spraying with p-anisaldehyde/sulfuric acid, ninhydrin, and Dragendorff's spray reagents (Wagner and Balt, 2001) . 1 H and 13 C NMR spec-tra were recorded in CDCl 3 with a Jeol JNA-LAA 400WB-FT ( 1 H, 400 MHz; 13 C, 100 MHz; Jeol, Tokyo, Japan) spectrometer with tetramethylsilane (TMS) as an internal standard. High-resolution ESI-MS was performed on a TQ-FT-ICR (liquid transfer quest-fourier transfer-ion cyclotron resonance) instrument. A Perkin Elmer (Santa Clara, CA, USA) Analyst 300 atomic absorption spectrometer was used for elemental analysis. Kits from Biomérieux (Craponne, France) were used for the determination of cholesterol, triglycerides, LDLc (low-density lipoprotein) and HDLc (highdensity lipoprotein). Simvastatin was obtained from Sigma-Aldrich (St. Louis, MO, USA).
Bioactivity-guided extraction and isolation
The powdered crown gall (1 kg) was extracted by percolation with 95% ethanol (4 x 2 l) at room temperature, followed by evaporation of the solvent under reduced pressure to yield 57 g of dried ethanolic extract. Forty g of the ethanolic residue were chromatographed over a VLC column (silica gel H, 200 g, 7 cm x 20 cm). Elution was carried out using successively n-hexane, CHCl 3 , EtOAc, and 50% (v/v) methanol in ethyl acetate. Fractions of 200 ml each were collected, subjected to TLC screening, and similar fractions were pooled to yield four major fractions (A -D) which were screened for anticancer and antihypercholesterolemic activities. The two biologically active fractions A and C were further purifi ed on silica gel columns. Fraction A (eluted with 100% n-hexane) was purifi ed over a silica gel 60 column using n-hexane and n-hexane/EtOAc (90:10, v/v). Seventy fractions each of 10 ml were collected and subjected to TLC on silica gel GF254 precoated plates, using n-hexane/EtOAc (80:20, v/v) as a solvent system. Fractions 18 -32 were pooled to yield compound 1 (33 mg, yellowish oil) after evaporation of the solvent, while the pooled fractions 43 -62 yielded compound 2 (243 mg, white amorphous powder). Fraction C (eluted with 100% ethyl acetate) was re-chromatographed over a silica gel 60 column using chloroform/methanol (96:4, v/v) as eluent. Thirty fi ve fractions each of 10 ml were collected and subjected to TLC on silica gel GF254 precoated plates, using chloroform/methanol (90:10, v/v) as a solvent system. Fractions 20 -30 were pooled to yield eventually compound 3 (110 mg, white microcrystalline powder).
Animals
Adult male Sprague-Dawley rats [130 -150 g body weight (BW)] were obtained from the animal house of the National Research Centre, Giza, Egypt. They were kept under hygienic conditions and were fed the basal diet recommended by the American Institute of Nutrition (AIN, 1977) , a semi-purifi ed diet that contained (g/kg BW): casein (200), sucrose (555), cellulose (100), fat blends (100) (cholesterol and lard, 1:5), vitamin mix (35), and mineral mix (35), for one week before the experiment. Water was supplied ad libitum. The temperature was maintained at (22  2) °C in a well ventilated room, with a relative humidity of 50 -60%, and with a 12-h cycle of light and dark. All rats were individually housed in metal cages. Care was taken to avoid stressful conditions. After adaptation, the rats were divided into seven groups of six animals each on the basis of body weight. All experimental procedures were performed between 8 -10 a.m. They were conducted in accordance with internationally accepted principles of laboratory animal use and care, and had been approved by the Ethics Committee of the National Research Centre (No. 9-031) in accordance with recommendations for the proper care and use of laboratory animals (NIH Publication No. 80-23; revised 1978) .
Determination of LD 50 values
One hundred and twenty adult male SpragueDawley rats were used to test the ethanolic extract of the crown gall as well as of fractions A -D. The animals of each group were divided into fi ve subgroups (n = 6) which received increasing doses of 100, 250, 500, and 1000 mg/kg BW daily for a period of 3 weeks. The animals were observed during the fi rst hour continuously, then every hour for 6 h, again after 12 and 24 h, and fi nally after every 24 h up to 3 weeks for any physical signs of toxicity such as writhing, gas ping, palpitation, and decreased respiratory rate or mortality. The LD 50 values of the ethanolic extract of the crown gall as well as of fractions A -D were calculated according to Karber (1931) .
Assessment of cytotoxic activity
The cytotoxicity of the ethanolic extract, its four subfractions, and the isolated compounds was measured using the sulforhodamine B assay (SRB) (Skehan et al., 1990) against two human cancer cell lines: colon cancer cell line (HCT116) and breast cancer cell line (MCF7), in which the cells were placed in a 96-multi-well plate (10 4 cells/ well) for 24 h before treatment with the test extracts to allow attachment of the cells to the wall of the plate. Different concentrations of each respective extract (0, 5, 12.5, 25, and 50 μg/ml) were added to the cell monolayer. Triplicate wells were incubated with the samples for 48 h at 37 °C in an atmosphere of 5% CO 2 . The cells were then fi xed, washed and stained with SRB stain. Excess stain was washed off with acetic acid and attached stain was recovered with Tris-EDTA buffer. The colour intensity was measured in an ELISA reader at 564 nm. The relation between surviving fraction and extract concentration was plotted to obtain the survival curve of each tumour cell line for the specifi ed test compound. The curves were fi tted using linear regression, and IC 50 was calculated.
The assessment was performed in the National Cancer Institute (NCI) in Egypt. The IC 50 (concentration which reduces the survival to 50%) and IC 10 (concentration which reduces the survival to 10%) values for each test sample were calculated and compared to those of the reference drug doxorubicin ® .
Assessment of antihyperlipidemic effect
The antihyperlipidemic effect of the ethanolic extract, its four subfractions, and compound 3 were evaluated by administration of an oral daily dose of 100 mg/kg BW of each of the test samples and compared to simvastatin as a standard drug (at the same dose level). Hyperlipidemia was induced according to the procedure of Neiy et al. (1988) and assessed by measuring serum cholesterol (Allain et al., 1974) , triglycerides (Bucolo and David, 1973) , HDLc, and LDLc levels (Stein, 1986) , using Biomérieux kits. The risk factor (LDLc/HDLc) was also calculated.
Statistical analysis
Results were expressed as mean  standard error of the mean (S.E.M.) for six rats in each group. Data were analysed using one-way analysis of variance (ANOVA).
Results and Discussion
The ethanolic extract of the crown gall induced on an Eucalyptus tereticornis Sm. tree was tested for its anticancer and antihyperlipidemic activities, after it had proven to be safe for administration based on its high LD 50 value (8.3 g/ kg BW). The results (Tables I and II) revealed its potent anticancer action against MCF7 (IC 50 0.94 μg/ml) and HCT116 (IC 50 1.61 μg/ml) cells and also its signifi cant antihyperlipidemic action, as it lowered the risk factor to 0.89 and caused a decrease of about 74% in the level of LDLc and an increase of about 80% in the level of HDLc after 8 weeks of administration of 100 mg/kg BW. Subsequently, these two effects served as the basis for the bioactivity-guided fractionation of the extract. Fractionation of the ethanolic extract yielded four major fractions, A -D, which were screened for the above mentioned activities. The two fractions A and C exhibited cytotoxic activ- ity against MCF7 (IC 50 0.60 and 0.67 μg/ml, respectively) and against HCT116 cells (IC 50 0.67 and 1.95 μg/ml, respectively) ( Table I ), but only fraction C signifi cantly reduced the risk factor in the treated group to 1.62 and caused a 50% decrease in LDLc and an 127% increase in HDLc levels (Table II) . Since the LD 50 values of fractions A and C confi rmed their safety up to 7.9 and 7.6 g/kg BW, respectively, these two fractions were selected for further purifi cation. Repeated CC of fractions A and C resulted in the isolation of two new cytotoxic compounds, the amino acid derivative 1 (33 mg) and the lanostane triterpene 2 (243 mg) from fraction A, in addition to the known compound 3 (110 mg) from fraction C.
Compound 1 was isolated as yellowish oil; it responded positively to ninhydrin reagent which suggested its nitrogenous nature. The ESI mass spectrum of compound 1 in the positive mode gave a molecular ion peak [M + H] + at m/z 246.18, compatible with the molecular formula C 16 H 23 NO. The elemental analysis of compound 1 showed the presence of C (78.32%), H (9.45%), N (5.71%), and O (6.52%). The spectroscopic The extract, fractions, compound 3, and simvastatin were given in a dose of 100 mg/kg BW. * Statistically signifi cant difference from zero time at P < 0.01. -Percentage decrease. + Percentage increase.
analysis of compound 1 supported that it is a derivative of an aromatic amino acid. The 1 H NMR spectrum of compound 1 (Table III) showed the presence of two aromatic signals (m, each) at δ H 7.70 and 7.52 ppm integrated to fi ve protons which correspond to fi ve aromatic protons present on a mono-substituted aromatic ring assigned to H-2", -3", -4", -5", and -6". The 13 C NMR spectroscopic data of 1 (Table III) showed 16 signals (two coincided at δ C 128.7 and 130.8 ppm); six aromatic carbon atoms, one attached to the nitrogen atom, three methyl carbon atoms, one methine carbon atom, and one carbonyl carbon atom at δ C 167.7 ppm indicating the presence of a carbonyl group involved in a cyclic amide linkage (Semak et al., 2010) . Direct correlations of protons to their respective carbon atoms were revealed in the HMQC spectrum. The structure of 1 was confi rmed by the key HMBC [H-6/C-5, C-2, C-1', C-4, C-3; H-2", H-6"/C1", C-3", C-4", and C-5"; H-3", H-5"/C-2" and C-6"; H 3 -2' and H 3 -3'/C-1', C-6; H-3/C-2] correlations. On the basis of the above evidences, the structure of 1 was elucidated as 1-ethyl-6-(1'-methyl-1'-phenylethyl) piperidin-2-one ( Fig. 1) which is a new natural product.
Compound 2 was isolated as a white amorphous powder. The ESI mass spectrum of compound 2 in the negative mode gave a molecular ion peak [M -H] + at m/z 481.38, compatible with the molecular formula C 32 H 50 O 3 . The 1 H NMR spectrum (Table IV) displayed a total of eight methyl signals, i.e., two secondary methyl groups at δ H 0.92 ppm (d, J = 6.8 Hz) and six tertiary methyl groups at δ H 0.68, 0.69, 0.78, 0.82, 0.86, and 1.43 ppm, an oxymethine group at δ H 2.98 ppm (m), and two allylic protons at δ H 4.71 and 4.63 ppm (each s). The 13 C NMR spectrum displayed 32 carbon signals, due to eight methyl carbon atoms, three methine carbon atoms (including one oxymethine group at δ C 76.7 ppm), one quaternary carbon atom (a carbonyl at δ C 176.5 ppm), and six olefi nic carbon atoms at δ C 106.7, 125.0, 133.3, 134.2 (two signals overlapped), and 156.0 ppm. The long-range 1 H-13 C NMR correlations indicated that 2 is a lanostane triterpenoidal derivative with the same A -D ring system as pisosterol (Gill et al., 1989; Zamuner et al., 2005) . This was clear from the HMBC correlations between the protons of the allylic methyl group at δ H 1.43 ppm (of CH 3 -21) -hydroxy-24-methyllanosta-8,17(20) ,24(28)-trien-22-oic acid (Fig. 1) which is a new natural product.
Compound 3 was identifi ed as stigmasterol-3-O-glucoside (Fig. 1) by comparison of its spectroscopic data with reported values (Akisha et al., 1988; Leitao et al., 1992; Goad and Akihisa, 1997) .
The three isolated compounds were consequently examined for their cytotoxic activity against the two tested human cancer cell lines, MCF7 and HCT116, while compound 3 only was tested for its antihyperlipidemic effect, as fraction C had proven to be the only active fraction with antihyperlipidemic activity. Compounds 1, 2, and 3 exerted signifi cant cytotoxic activity against MCF7 cells with IC 50 values of 1.01, 1.54, and 2.15 μg/ml, respectively, and 3.49, 3.83, and 3.39 μg/ml against HCT116 cells, respectively. Previous investigations reported cytotoxic activity of lanostane triterpenes too (Ukiya and Akihisa, 2002; Akihisa et al., 2007; Monténégro et al., 2008; Zhou et al., 2008; Arpha et al., 2012) . As compound 2 was found to be cytotoxic against the human cancer cell lines studied here, our results provide further support for the cytotoxic activity of lanostane triterpenes. Ghosh et al. (2011) reported that stigmasterol decreased the tumour volume, packed cell volume, and viable cell count in Ehrlich ascites carcinoma (EAC)-bearing mice, and increased the mean survival time, thereby extending their life span. In our present study, stigmasterol-3-O-glucoside (3) exerted signifi cant cytotoxic activity against the tested human cancer cell lines, which is in good agreement with previous studies. Reduction of the blood cholesterol level by administration of drugs or by modifi cation of the diet decreases the risk of coronary diseases ( Daksha et al., 2010) . Clinical trials revealed that a one percent reduction in total cholesterol causes a two percent reduction in heart attacks (NIH Reports, 1988) . Compound 3 proved promising antihyperlipidemic activity, as it reduced the risk factor in the treated group to 1.10, as compared to the time before the onset of treatment, and caused an almost 69% decrease in LDLc and 136% increase in HDLc (Table II) . Plant sterols have been reported to be effective in lowering plasma total cholesterol and LDL cholesterol by virtue of inhibiting the absorption of cholesterol from the small intestine (Sabir et al., 2003) . Phytosterols are cholesterol-like molecules absorbed only in trace amounts, but they inhibit the absorption of intestinal cholesterol including recirculating endogenous biliary cholesterol, and this is a key step in cholesterol elimination (Daksha et al., 2010) .
Colorectal cancer (CRC) is one of the most common neoplasms of the digestive system and one of the most lethal causes of cancer death worldwide. The most studied risk factors cau sing CRC development are heredity, age, low-fi ber and high-fat diet, alcohol, tobacco use, obesity, low physical activity, and environmental pollution. All of these factors could lead to hypercholesterolemia, which in turn increases the risk of CRC development (Herbey et al., 2005) . Hyperlipidemia is a relatively frequent complication in FAP [familial adenomatous polyposis that results from germline adenomatous polyposis coli (APC) gene mutations]; many affected patients die from CRC which arises from colorectal polyps. Moreover, there is a tendency for higher serum triglyceride (TG) levels in patients who developed CRC. This suggests the possible link of hyperlipidemia to CRC development. Consequently, improving a hyperlipidemic state might be of benefi t for protection against neoplasia or other adverse outcomes (Mutoh et al., 2006) . Administration of statins was associated with a relative reduction in the risk of CRC (Poynter et al., 2005; Broughton et al., 2012) . In the present study, compound 3 reduced the risk factor, decreased the LDLc and increased the HDLc level (Table II) . On the other hand, it also exhibited a signifi cant cytotoxic activity against human colon cancer cells (HCT116) with an IC 50 value of (3.39  0.55) μg/ml. From these results we can presume a possible correlation between the reduction in hypercholesterolemia and the improvement in the incidence of CRC.
Conclusion
The ethanolic extract, fraction C, and stigmasterol-3-O-glucoside (3) of the crown gall tissues obtained from the tumour induced on an Eucalyptus tereticornis tree reduced the risk factors and thus prevented hypercholesterolemia. The two new compounds 1 and 2 showed a potent activity against both breast and colon cancer cell lines. Administration of 3 was associated with a lower incidence of CRC as well as a lower blood cholesterol level. Stigmasterol-3-O-glucoside may have a protective effect against the development of CRC, however, further studies examining the effects of stigmasterol-3-O-glucoside are required.
